US29109X1063 - Common Stock

**AZPN** gets a fundamental rating of **5** out of 10. The analysis compared the fundamentals against 280 industry peers in the **Software** industry. No worries on liquidiy or solvency for **AZPN** as it has an excellent financial health rating, but there are worries on the profitability. **AZPN** is quite expensive at the moment. It does show a decent growth rate.

In the past year **AZPN** was profitable.

In the past year **AZPN** had a positive cash flow from operations.

In the past 5 years **AZPN** always reported a positive cash flow from operatings.

The **Return On Assets** of **AZPN** (**-0.92%**) is better than **69.64%** of its industry peers.

Looking at the **Return On Equity**, with a value of **-1.01%**, **AZPN** is in the better half of the industry, outperforming **73.21%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.92% | ||

ROE | -1.01% | ||

ROIC | N/A |

ROA(3y)7.2%

ROA(5y)14.14%

ROE(3y)13.17%

ROE(5y)32.2%

ROIC(3y)N/A

ROIC(5y)N/A

With a **Gross Margin** value of **63.50%**, **AZPN** perfoms like the industry average, outperforming **46.79%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 63.5% |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-10.54%

GM growth 5Y-6.53%

The number of shares outstanding for **AZPN** remains at a similar level compared to 1 year ago.

Compared to 5 years ago, **AZPN** has less shares outstanding

The **Altman-Z score** of **AZPN** (**5.39**) is better than **73.93%** of its industry peers.

There is no outstanding debt for **AZPN**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | 0 | ||

Altman-Z | 5.39 |

ROIC/WACCN/A

WACC10.79%

A Quick Ratio of **2.26** indicates that **AZPN** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.26 | ||

Quick Ratio | 2.26 |

The earnings per share for **AZPN** have decreased strongly by **-34.81%** in the last year.

The **Revenue** has grown by **80.04%** in the past year. This is a very strong growth!

Measured over the past years, **AZPN** shows a quite strong growth in **Revenue**. The Revenue has been growing by **15.52%** on average per year.

EPS 1Y (TTM)-34.81%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-47.27%

Revenue 1Y (TTM)80.04%

Revenue growth 3Y20.37%

Revenue growth 5Y15.52%

Revenue growth Q2Q-0.6%

EPS Next Y11.55%

EPS Next 2Y17.6%

EPS Next 3Y10.89%

EPS Next 5Y15.91%

Revenue Next Year11.13%

Revenue Next 2Y13.34%

Revenue Next 3Y5.29%

Revenue Next 5Y14.37%

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

With a **Price/Earnings** ratio of **39.01**, **AZPN** can be considered very expensive at the moment.

71.07% of the companies in the same industry are more expensive than **AZPN**, based on the **Price/Earnings** ratio.

The **Price/Forward Earnings** ratio is **18.95**, which indicates a rather expensive current valuation of **AZPN**.

Based on the **Price/Forward Earnings** ratio, **AZPN** is valued cheaply inside the industry as 82.50% of the companies are valued more expensively.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **19.59**, **AZPN** is valued at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 39.01 | ||

Fwd PE | 18.95 |

75.71% of the companies in the same industry are more expensive than **AZPN**, based on the **Enterprise Value to EBITDA** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 38.36 | ||

EV/EBITDA | 38.56 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

PEG (NY)3.38

PEG (5Y)N/A

EPS Next 2Y17.6%

EPS Next 3Y10.89%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**ASPEN TECHNOLOGY INC**

NASDAQ:AZPN (11/28/2023, 7:00:00 PM)

After market: 183.36 0 (0%)**183.36**

**-0.59 (-0.32%) **

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)11-06 2023-11-06/amc

Earnings (Next)N/A N/A

Inst Owners45.1%

Inst Owner Change-1.03%

Ins Owners0.83%

Ins Owner Change10.08%

Market Cap11.69B

Analysts72

Price Target205.87 (12.28%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-12.46%

Min EPS beat(2)-21.21%

Max EPS beat(2)-3.7%

EPS beat(4)0

Avg EPS beat(4)-34.82%

Min EPS beat(4)-74.06%

Max EPS beat(4)-3.7%

Revenue beat(2)0

Avg Revenue beat(2)-5.71%

Min Revenue beat(2)-7.68%

Max Revenue beat(2)-3.73%

Revenue beat(4)0

Avg Revenue beat(4)-11.37%

Min Revenue beat(4)-21.09%

Max Revenue beat(4)-3.73%

PT rev (1m)3.59%

PT rev (3m)5.86%

EPS NQ rev (1m)0.77%

EPS NQ rev (3m)8.06%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)-3.71%

Revenue NQ rev (3m)-3.71%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 39.01 | ||

Fwd PE | 18.95 | ||

P/S | 11.21 | ||

P/FCF | 38.36 | ||

P/OCF | 37.57 | ||

P/B | 0.9 | ||

P/tB | 238.56 | ||

EV/EBITDA | 38.56 |

EPS(TTM)4.7

EY2.56%

EPS(NY)9.67

Fwd EY5.28%

FCF(TTM)4.78

FCFY2.61%

OCF(TTM)4.88

OCFY2.66%

SpS16.35

BVpS202.78

TBVpS0.77

PEG (NY)3.38

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.92% | ||

ROE | -1.01% | ||

ROCE | N/A | ||

ROIC | N/A | ||

ROICexc | N/A | ||

ROICexgc | N/A | ||

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 63.5% | ||

FCFM | 29.23% |

ROA(3y)7.2%

ROA(5y)14.14%

ROE(3y)13.17%

ROE(5y)32.2%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-10.54%

GM growth 5Y-6.53%

F-Score5

Asset Turnover0.07

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | 0 | ||

Debt/EBITDA | 0 | ||

Cap/Depr | 1.3% | ||

Cap/Sales | 0.61% | ||

Interest Coverage | N/A | ||

Cash Conversion | 103.7% | ||

Profit Quality | N/A | ||

Current Ratio | 2.26 | ||

Quick Ratio | 2.26 | ||

Altman-Z | 5.39 |

F-Score5

WACC10.79%

ROIC/WACCN/A

Cap/Depr(3y)9.15%

Cap/Depr(5y)12.36%

Cap/Sales(3y)0.6%

Cap/Sales(5y)0.46%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y (TTM)-34.81%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-47.27%

EPS Next Y11.55%

EPS Next 2Y17.6%

EPS Next 3Y10.89%

EPS Next 5Y15.91%

Revenue 1Y (TTM)80.04%

Revenue growth 3Y20.37%

Revenue growth 5Y15.52%

Revenue growth Q2Q-0.6%

Revenue Next Year11.13%

Revenue Next 2Y13.34%

Revenue Next 3Y5.29%

Revenue Next 5Y14.37%

EBIT growth 1Y-13621.4%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year20.3%

EBIT Next 3Y8.87%

EBIT Next 5Y9.77%

FCF growth 1Y34.58%

FCF growth 3Y6.51%

FCF growth 5Y7.23%

OCF growth 1Y35.03%

OCF growth 3Y7.14%

OCF growth 5Y7.66%